Initial exploration of a novel fusion protein, IL-4/IL-34/IL-10, which promotes cardiac allograft survival mice through alloregulation
In conclusion, newly developed FP1 improves the graft survival in cardiac transplantation mouse model. Significant additional work to optimize FP1 or include other novel proteins could supplement current treatment options for transplant patients.PMID:37800911 | DOI:10.1177/17534259231186239
Source: Innate Immunity - Category: Allergy & Immunology Authors: Young S Lee I-Ting Cheng Godoy-Ruiz Raquel David J Weber Joseph R Scalea Source Type: research
More News: Allergy & Immunology | Bone Graft | Cardiology | Heart | Heart Transplant | Transplant Surgery | Transplants